相关实验视频
Updated: Jun 3, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
288
医学治疗库辛综合征的治疗方法
Laurence Guignat1, Jerome Bertherat1,2
1Department of Endocrinology and National Reference Center for Rare Adrenal Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
Endocrinology and metabolism (Seoul, Korea)
|January 13, 2025
概括
内源性库辛综合征 (CS) 是一种罕见的疾病,由过多的皮质醇引起. 这篇评论详细介绍了当手术不是一种选择时,CS的当前医学疗法,强调了疗效和安全性.
科学领域:
- 内分泌学 在内分泌学.
- 内部医学 内部医学
背景情况:
- 内源性库辛综合征 (CS) 由慢性皮质醇过量引起,导致严重的并发病,降低生活质量和增加死亡率.
- 脑脊髓瘤管理是复杂的,手术切除瘤是主要的治疗方法.
- 当手术不可行或失败时,非手术选择至关重要.
研究的目的:
- 为提供对内源性库辛综合征的当前医学疗法的概述.
- 讨论CS可用的药理疗法的疗效,安全性和管理.
- 确定在CS管理中需要改进的向疗法.
主要方法:
- 这篇小评论综合了关于库辛综合征的医学治疗方法的信息.
- 它研究了各种药物的疗效,安全性概况和患者管理策略.
- 该审查考虑了基于专家建议和患者偏好的个性化治疗方法.
主要成果:
- 有几种医疗疗法可用于CS管理,当手术不是一种选择时.
- 目前的治疗方法需要仔细监测患者和护理人员的教育.
- 新的药物已经出现,但在CS治疗方面仍然存在挑战.
结论:
- 医疗治疗是治疗库辛综合征的重要组成部分,特别是当手术禁忌或不成功时.
- 个性化治疗计划和密切监测对于优化患者的治疗结果至关重要.
- 需要进一步开发有针对性的药理疗法,以提高CS治疗的疗效和安全性.
相关概念视频
Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141

